Clinical Trial Update: An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial evaluating an immunotherapy vaccine called PIpepTolDC for the treatment of Type 1 Diabetes Mellitus, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• PIpepTolDC

Snippet

Sponsor: City of Hope Medical Center | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: ACTIVE_NOT_RECRUITING